New malaria vaccines aim to stop spread in kids and adults
NCT ID NCT06549257
First seen Mar 01, 2026 · Last updated May 25, 2026 · Updated 12 times
Summary
This study tests two experimental vaccines designed to stop the malaria parasite from spreading from person to person. The vaccines are given to healthy adults, teens, and children aged 5–45 in Burkina Faso, where malaria is common. The main goal is to check safety and see how well the vaccines trigger an immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut des Sciences et Techniques (INSTech)
Bobo-Dioulasso, 01 BP 2779, Burkina Faso
Conditions
Explore the condition pages connected to this study.